Chronic lymphocytic leukemia FISH panel: impact on diagnosis
- PMID: 17638669
- DOI: 10.1309/21TN2RUWKR827UW2
Chronic lymphocytic leukemia FISH panel: impact on diagnosis
Abstract
Interphase fluorescence in situ hybridization (FISH) is an alternative to conventional chromosome analysis of chronic lymphocytic leukemia (CLL) cells. We analyzed 172 samples from 136 possible CLL cases using a FISH panel. Reflex testing with probes to CCND1, BCL2, BCL3, BCL11A, c-MYC, MALT1, and a break-apart immunoglobulin heavy chain (IGH) probe was done if more than 2 signals for 14q32 occurred. For 111 cases, there were sufficient data for analysis. Of 111 cases, 81 (72.9%) had 1 or more genetic abnormalities. The most frequent abnormality was 13q-, followed by trisomy 12, 11q-, and 17p-. In 13 cases, there were IGH abnormalities. Two cases with CCND1/IGH fusion were reclassified as mantle cell lymphoma. Four CLL cases had IGH fusion with BCL2, BCL3 (2 cases), and BCL11A; no fusion partner was detected in 7 cases. Morphologic features were atypical for CLL in 2 cases with IGH fusion (BCL11A and BCL3). The FISH CLL panel is useful to identify prognostic aberrations and to clarify diagnosis in cases with unusual morphologic features.
Similar articles
-
Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia.Br J Haematol. 2005 Jul;130(1):36-42. doi: 10.1111/j.1365-2141.2005.05548.x. Br J Haematol. 2005. PMID: 15982342
-
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis.Br J Haematol. 2008 Aug;142(4):529-37. doi: 10.1111/j.1365-2141.2008.07227.x. Epub 2008 Jun 28. Br J Haematol. 2008. PMID: 18547320
-
Chronic lymphocytic leukaemia profiled for prognosis using a fluorescence in situ hybridisation panel.Br J Haematol. 2006 Mar;132(6):705-22. doi: 10.1111/j.1365-2141.2005.05919.x. Br J Haematol. 2006. PMID: 16487171
-
Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemia.Best Pract Res Clin Haematol. 2007 Sep;20(3):439-53. doi: 10.1016/j.beha.2007.02.006. Best Pract Res Clin Haematol. 2007. PMID: 17707832 Review.
-
Chronic lymphocytic leukemia developing in a patient with chronic myeloid leukemia: evidence of distinct lineage-associated genomic events.Cancer Genet Cytogenet. 2005 Aug;161(1):74-7. doi: 10.1016/j.cancergencyto.2005.01.008. Cancer Genet Cytogenet. 2005. PMID: 16080961 Review.
Cited by
-
Prognostic Factors in the Era of Targeted Therapies in CLL.Curr Hematol Malig Rep. 2018 Apr;13(2):78-90. doi: 10.1007/s11899-018-0439-9. Curr Hematol Malig Rep. 2018. PMID: 29473123 Review.
-
Chronic Lymphocytic Leukemia with t(14;18)(q32;q21) As a Sole Cytogenetic Abnormality.Clin Med Insights Pathol. 2014 Sep 23;7:21-7. doi: 10.4137/CPath.S17818. eCollection 2014. Clin Med Insights Pathol. 2014. PMID: 25288894 Free PMC article.
-
The Heterogeneity of 13q Deletions in Chronic Lymphocytic Leukemia: Diagnostic Challenges and Clinical Implications.Genes (Basel). 2025 Feb 22;16(3):252. doi: 10.3390/genes16030252. Genes (Basel). 2025. PMID: 40149404 Free PMC article. Review.
-
Importance of immunoglobulin heavy chain variable region mutational status in del(13q) chronic lymphocytic leukemia.Leuk Lymphoma. 2011 Oct;52(10):1873-81. doi: 10.3109/10428194.2011.585529. Epub 2011 Aug 18. Leuk Lymphoma. 2011. PMID: 21851216 Free PMC article.
-
An Incidental Finding of Gain of a Diminished Chromosome 12 Centromere in an Individual with Lymphocytosis: A Case Report and Clinical Implications in Cytogenetic Testing.Diagnostics (Basel). 2025 Mar 4;15(5):618. doi: 10.3390/diagnostics15050618. Diagnostics (Basel). 2025. PMID: 40075865 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials